A Léotard1,2, M Delorme3,4, S Hartley5, C Khouri4, M Lebret3, F Lofaso5,3, J-L Pepin6, J-C Borel7. 1. Département de Physiologie, explorations fonctionnelles unité des pathologies du sommeil, AP-HP, Hôpital Raymond Poincaré, 104 Boulevard Raymond Poincaré, 92380, Garches, France. antoine.leotard@aphp.fr. 2. Université Versailles-Saint-Quentin-en-Yvelines, « End:icap » U1179 Inserm, Versailles, France. antoine.leotard@aphp.fr. 3. Université Paris-Saclay, UVSQ, ERPHAN, 78000, Versailles, France. 4. Direction Des Actions Médicales, AFM-Téléthon, 91000, Evry, France. 5. Département de Physiologie, explorations fonctionnelles unité des pathologies du sommeil, AP-HP, Hôpital Raymond Poincaré, 104 Boulevard Raymond Poincaré, 92380, Garches, France. 6. HP2 Laboratory, Univ. Grenoble Alpes, INSERM U1300, Grenoble, France. 7. AGIR À Dom. Association, Meylan, France.
Abstract
PURPOSE: In patients with COPD, one of the leading indications for domiciliary non-invasive ventilation (NIV), a major paradigm shift has been observed over the past decade in the method for adjusting NIV settings, with the use of sufficient ventilatory support to achieve a significant reduction in PaCO2. Whether this approach may be relevant to other populations, especially slowly progressive neuromuscular diseases (NMD), is unknown. METHODS: This study was conducted as a post hoc analysis from a previously published randomized controlled trial (NCT03458507). Patients with NMD treated with domiciliary NIV were stratified according to the level of ventilatory support: high-level tidal volume (HLVT; mL/kg of predicted body weight [PBW]) or high-level pressure support (HLPS), defined as a value above median value of the whole population (> 6.8 mL/kgPBW or 9.0 cmH2O, respectively). Primary outcome was mean nocturnal transcutaneous CO2 pressure (PtcCO2). Secondary outcomes included adherence to NIV, leaks, and side effects. RESULTS: Of a total of 26 patients, 13 were exposed to HLVT, with significantly lower nocturnal PtcCO2 (respectively 40.5 ± 4.2 vs. 46.3 ± 3.9 mmHg, p = 0.002). A linear correlation between VT (mL/kgPBW) and mean nocturnal PtcCO2 was evidenced (r = - 0.59, 95%CI [- 0.80; - 0.25], p = 0.002). No significant impact of HLVT was found on secondary outcomes. CONCLUSION: Despite the lack of power of this post hoc analysis, our results suggest that higher levels of ventilatory support are correlated with lower PtcCO2 in patients with NMD. Further studies are desirable to assess the extent to which the level of assistance influences PaCO2 evolution in patients with slowly progressive NMD, as well as in restrictive thoracic disorders.
PURPOSE: In patients with COPD, one of the leading indications for domiciliary non-invasive ventilation (NIV), a major paradigm shift has been observed over the past decade in the method for adjusting NIV settings, with the use of sufficient ventilatory support to achieve a significant reduction in PaCO2. Whether this approach may be relevant to other populations, especially slowly progressive neuromuscular diseases (NMD), is unknown. METHODS: This study was conducted as a post hoc analysis from a previously published randomized controlled trial (NCT03458507). Patients with NMD treated with domiciliary NIV were stratified according to the level of ventilatory support: high-level tidal volume (HLVT; mL/kg of predicted body weight [PBW]) or high-level pressure support (HLPS), defined as a value above median value of the whole population (> 6.8 mL/kgPBW or 9.0 cmH2O, respectively). Primary outcome was mean nocturnal transcutaneous CO2 pressure (PtcCO2). Secondary outcomes included adherence to NIV, leaks, and side effects. RESULTS: Of a total of 26 patients, 13 were exposed to HLVT, with significantly lower nocturnal PtcCO2 (respectively 40.5 ± 4.2 vs. 46.3 ± 3.9 mmHg, p = 0.002). A linear correlation between VT (mL/kgPBW) and mean nocturnal PtcCO2 was evidenced (r = - 0.59, 95%CI [- 0.80; - 0.25], p = 0.002). No significant impact of HLVT was found on secondary outcomes. CONCLUSION: Despite the lack of power of this post hoc analysis, our results suggest that higher levels of ventilatory support are correlated with lower PtcCO2 in patients with NMD. Further studies are desirable to assess the extent to which the level of assistance influences PaCO2 evolution in patients with slowly progressive NMD, as well as in restrictive thoracic disorders.
Authors: Jan H Storre; Elena Matrosovich; Emelie Ekkernkamp; David J Walker; Claudia Schmoor; Michael Dreher; Wolfram Windisch Journal: Respir Care Date: 2014-07-29 Impact factor: 2.258
Authors: Babak Mokhlesi; Juan Fernando Masa; Majid Afshar; Virginia Almadana Pacheco; David J Berlowitz; Jean-Christian Borel; Stephan Budweiser; Andres Carrillo; Olalla Castro-Añón; Miquel Ferrer; Frédéric Gagnadoux; Rafael Golpe; Nicholas Hart; Mark E Howard; Patrick B Murphy; Andreas Palm; Luis A Perez de Llano; Amanda J Piper; Jean Louis Pépin; Pascaline Priou; Jesús F Sánchez-Gómez; Israa Soghier; Maximiliano Tamae Kakazu; Kevin C Wilson Journal: Ann Am Thorac Soc Date: 2020-05
Authors: Juan F Masa; Iván Benítez; Maria Á Sánchez-Quiroga; Francisco J Gomez de Terreros; Jaime Corral; Auxiliadora Romero; Candela Caballero-Eraso; Maria L Alonso-Álvarez; Estrella Ordax-Carbajo; Teresa Gomez-Garcia; Mónica González; Soledad López-Martín; José M Marin; Sergi Martí; Trinidad Díaz-Cambriles; Eusebi Chiner; Carlos Egea; Javier Barca; Francisco J Vázquez-Polo; Miguel A Negrín; María Martel-Escobar; Ferrán Barbé; Babak Mokhlesi Journal: Chest Date: 2020-04-25 Impact factor: 9.410
Authors: Patrick B Murphy; Sunita Rehal; Gill Arbane; Stephen Bourke; Peter M A Calverley; Angela M Crook; Lee Dowson; Nicholas Duffy; G John Gibson; Philip D Hughes; John R Hurst; Keir E Lewis; Rahul Mukherjee; Annabel Nickol; Nicholas Oscroft; Maxime Patout; Justin Pepperell; Ian Smith; John R Stradling; Jadwiga A Wedzicha; Michael I Polkey; Mark W Elliott; Nicholas Hart Journal: JAMA Date: 2017-06-06 Impact factor: 56.272
Authors: Antoine Léotard; Marius Lebret; Najeh Daabek; Hélène Prigent; Marie Destors; Christel Saint-Raymond; Amélie Sagniez; Karl Leroux; Renaud Tamisier; Frédéric Lofaso; Jean Louis Pépin; Jean Christian Borel Journal: Arch Bronconeumol (Engl Ed) Date: 2020-06-23 Impact factor: 4.872
Authors: Babak Mokhlesi; Juan Fernando Masa; Jan L Brozek; Indira Gurubhagavatula; Patrick B Murphy; Amanda J Piper; Aiman Tulaimat; Majid Afshar; Jay S Balachandran; Raed A Dweik; Ronald R Grunstein; Nicholas Hart; Roop Kaw; Geraldo Lorenzi-Filho; Sushmita Pamidi; Bhakti K Patel; Susheel P Patil; Jean Louis Pépin; Israa Soghier; Maximiliano Tamae Kakazu; Mihaela Teodorescu Journal: Am J Respir Crit Care Med Date: 2019-08-01 Impact factor: 21.405